This commentary proposes a research agenda that could inform policymaking based on a broader understanding the economic and social costs and benefits of specialty pharmaceuticals.
Brian Gifford, PhD
Advertisement
Articles by Brian Gifford, PhD
Advertisement
Latest Updated Articles
- Specialty Pharmaceuticals: An Agenda for Health and Productivity Research
Published: June 21st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
3
FDA Approves Gazyva for Active Lupus Nephritis
4
Turning the Tide in TNBC: Trop2-Targeted Therapies Improve Patient Outcomes
5
